Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: May 20, 2022

PRASUGREL Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Prasugrel, and when can generic versions of Prasugrel launch?

Prasugrel is a drug marketed by Accord Hlthcare, Amneal Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Hec Pharm, Mylan, Panacea, and Uspharma Windlas. and is included in eight NDAs.

The generic ingredient in PRASUGREL is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.

Drug patent expirations by year for PRASUGREL
Drug Prices for PRASUGREL

See drug prices for PRASUGREL

Recent Clinical Trials for PRASUGREL

Identify potential brand extensions & 505(b)(2) entrants

Mayo ClinicPhase 4
Vastra Gotaland RegionPhase 4
Region SkanePhase 4

See all PRASUGREL clinical trials

Pharmacology for PRASUGREL

US Patents and Regulatory Information for PRASUGREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare PRASUGREL prasugrel hydrochloride TABLET;ORAL 205987-001 Feb 2, 2018 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Dr Reddys Labs Ltd PRASUGREL prasugrel hydrochloride TABLET;ORAL 205926-001 Jul 7, 2020 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Amneal Pharms PRASUGREL prasugrel hydrochloride TABLET;ORAL 205913-002 Jun 19, 2018 BX RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.